Merck Other Non-Current Liabilities 2010-2024 | MKKGY
Merck other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Merck other non-current liabilities for the quarter ending June 30, 2024 were $2.678B, a 1.2% decline year-over-year.
- Merck other non-current liabilities for 2023 were $2.892B, a 8.58% increase from 2022.
- Merck other non-current liabilities for 2022 were $2.664B, a 41.28% decline from 2021.
- Merck other non-current liabilities for 2021 were $4.536B, a 8.14% decline from 2020.
Merck Annual Other Non-Current Liabilities
(Millions of US $) |
| 2023 |
$2,892 |
| 2022 |
$2,664 |
| 2021 |
$4,536 |
| 2020 |
$4,938 |
| 2019 |
$4,013 |
| 2018 |
$3,741 |
| 2017 |
$3,842 |
| 2016 |
$3,968 |
| 2015 |
$3,662 |
| 2014 |
$4,291 |
| 2013 |
$2,560 |
| 2012 |
$2,717 |
| 2011 |
$8,281 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2024-06-30 |
$2,678 |
| 2024-03-31 |
$2,825 |
| 2023-12-31 |
$2,892 |
| 2023-09-30 |
$2,451 |
| 2023-06-30 |
$2,711 |
| 2023-03-31 |
$2,652 |
| 2022-12-31 |
$2,664 |
| 2022-09-30 |
$2,487 |
| 2022-06-30 |
$2,281 |
| 2022-03-31 |
$3,774 |
| 2021-12-31 |
$4,536 |
| 2021-09-30 |
$4,475 |
| 2021-06-30 |
$4,629 |
| 2021-03-31 |
$4,598 |
| 2020-12-31 |
$4,938 |
| 2020-09-30 |
$16,222 |
| 2020-06-30 |
$4,320 |
| 2020-03-31 |
$3,802 |
| 2019-12-31 |
$4,013 |
| 2019-09-30 |
$4,929 |
| 2019-06-30 |
$4,316 |
| 2019-03-31 |
$4,068 |
| 2018-12-31 |
$3,741 |
| 2018-09-30 |
$3,459 |
| 2018-06-30 |
$3,758 |
| 2018-03-31 |
$3,924 |
| 2017-12-31 |
$3,842 |
| 2017-09-30 |
$4,004 |
| 2017-06-30 |
$3,687 |
| 2017-03-31 |
$3,740 |
| 2016-12-31 |
$3,968 |
| 2016-09-30 |
$4,435 |
| 2016-06-30 |
$4,280 |
| 2016-03-31 |
$3,970 |
| 2015-12-31 |
$3,662 |
| 2015-09-30 |
$3,550 |
| 2015-06-30 |
$3,357 |
| 2015-03-31 |
$4,107 |
| 2014-12-31 |
$4,291 |
| 2014-09-30 |
$2,612 |
| 2014-06-30 |
$3,028 |
| 2014-03-31 |
$2,895 |
| 2013-12-31 |
$2,560 |
| 2013-09-30 |
$2,978 |
| 2013-06-30 |
$3,012 |
| 2013-03-31 |
$3,001 |
| 2012-12-31 |
$2,717 |
| 2012-09-30 |
$6,885 |
| 2012-06-30 |
$7,943 |
| 2012-03-31 |
|
| 2011-12-31 |
$8,281 |
| 2011-09-30 |
|
| 2011-06-30 |
$9,591 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$9,323 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
